MSCV-19a-20-19b Citations (2)

Originally described in: miR-19 is a key oncogenic component of mir-17-92.
Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, Cordon-Cardo C, Li QJ, Lowe SW, Hannon GJ, He L Genes Dev. 2009 Dec 15. 23(24):2839-49. PubMed Journal

---

Articles Citing MSCV-19a-20-19b

Articles
Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia. Reynolds C, Roderick JE, LaBelle JL, Bird G, Mathieu R, Bodaar K, Colon D, Pyati U, Stevenson KE, Qi J, Harris M, Silverman LB, Sallan SE, Bradner JE, Neuberg DS, Look AT, Walensky LD, Kelliher MA, Gutierrez A. Leukemia. 2014 Sep;28(9):1819-27. doi: 10.1038/leu.2014.78. Epub 2014 Feb 20. PubMed
Spermine synthase and MYC cooperate to maintain colorectal cancer cell survival by repressing Bim expression. Guo Y, Ye Q, Deng P, Cao Y, He D, Zhou Z, Wang C, Zaytseva YY, Schwartz CE, Lee EY, Mark Evers B, Morris AJ, Liu S, She QB. Nat Commun. 2020 Jun 26;11(1):3243. doi: 10.1038/s41467-020-17067-x. PubMed

If you have published an article using this material, please email us at to have your article added to this page.